Ning Go

Ning Go is currently the Director of Diagnostics Strategy at Amgen, where they lead companion diagnostics development in oncology and cardiovascular therapeutic areas. They have been with Amgen since 2012, serving as a Principal Scientist before their current role. Ning has extensive experience in IVD strategy, regulatory submissions, and managing cross-functional project teams throughout their career. They previously held positions at Geron Corp., Affymax Research Institute, and Stanford University School of Medicine, and completed post-doctoral fellowships that contributed to key advancements in immunology and pharmacology. Ning is pursuing a Master of Arts in Immunology from the University of California, Berkeley, alongside their Doctor of Medicine from Beijing University Medical School.